| 50 |
What is the position of sichuan Daewoong Bio ? |
|
We, sichuan Daewoong Bio is located in Meishan city of Sichuan Province, China. This area is very comvenient to communicate with same industry companies.
|
| 49 |
What is the future plan of sichuan Daewoong Bio ? |
|
We, sichuan Daewoong Bio try to produce high-quality CDCA, at same thing trying to improve yeild. We, sichuan Daewoong Bio, will do our best to be world-best CDCA production company. We will control quality, becoming global market competitiveness
|
| 48 |
How many does the production of sichuan Daewoong Bio has ? |
|
The produce of our main product CDCA is 4tons per month. Our aim is 5tons per month.
|
| 47 |
what is the production of sichuan Daewoong Bio ? |
|
We, sichuan Daewoong Bio the main product is CDCA and as a byproduct in the production of bile acid , HDCA, CA.
|
| 46 |
What kind of dosage forms are producted in Anseong Plnat? |
|
We products uncoated, coated tablets, dry syrups.
|
| 45 |
When did Anseong Plant get the KFDA Permission? |
|
Anseong Plant got the KFDA permission in 2008.
|
| 44 |
What are the newest facilities in the Hyangnam plants? |
|
We have a filter & dryer that can filter, clean and dry at one time and solvent recovery facilities which can input solvent by digital systems. Also, we always operate air system, which won't be influenced by summer and winter weather, to manufacture products in pleasant environment.
|
| 43 |
What was the main concerns and strategies of Hyangnam plant? |
|
We designed two exclusive manufacturing buildings for general APIs and Carbapenem APIs with spare areas for future use. As a certified PSM plant, we paid attention to design a good strucuture of exclusive manufacutring area and automated operation facilities for effective operation.
|
| 42 |
How many employees in Hyangnam Plant? |
|
We have 145 employees including production division and support division.
|
| 41 |
What do you mainly produce? |
|
Our main product is manufacturing UDCA by total synthesis. We also produce Cephalosporins at the Plant 1, UDCA intermediates at the Plant 2, and general APIs and Carbapenems at the Plant 3.
|
1 
